Concepedia

Weijia Yu

WY

Statistics

Publications

3

Citations

102

H-Index

3

Active since

2021

Affiliations

Heidelberg University(Current)

Goethe University Frankfurt

Frankfurt Cancer Institute

Cardio-Pulmonary Institute

German Cancer Research Center

Weijia Yu is an author at Heidelberg University specializing in life sciences, chemokine signaling, and caspase-mediated apoptosis.

ORCID

Publications per year

2021–2025

3

Publications

3

GPR182 is an endothelium-specific atypical chemokine receptor that maintains hematopoietic stem cell homeostasis

Alan Le Mercier, Rémy Bonnavion, Weijia Yu et al. · Proceedings of the National Academy of Sciences · 2021 · 46 citations · Full text

, , +17

Transglutaminase 2 promotes tumorigenicity of colon cancer cells by inactivation of the tumor suppressor p53

Patrizia Malkomes, Ilaria Lunger, Elsie Oppermann et al. · Oncogene · 2021 · 40 citations · Full text

, , +6

Continuous map of early hematopoietic stem cell differentiation across human lifetime

Hana Komic, Tessa Schmachtel, Catia Simoes et al. · Nature Communications · 2025 · 16 citations · Full text

, , +17

1–3 of 3